| Dr Brandt Michael Riley, DO | |
|
Hwy 122, Mason City, IA 50402-1877 | |
| (641) 423-8861 | |
| (641) 423-0727 |
| Full Name | Dr Brandt Michael Riley |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 20 Years |
| Location | Hwy 122, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306064324 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 34-8629 (Ohio) | Secondary |
| 207W00000X | Ophthalmology | 3892 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mitchell County Regional Health | Osage, IA | Hospital |
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Iowa Eye Clinic, P.c. | 8426949173 | 5 |
News Archive
AlphaRx Inc. announced today that its licensee, Gaia BioPharma Limited, has signed an agreement with a contract manufacturing organization (CMO), to manufacture GAI-122 for use in the planned Phase I and II clinical trials of that product candidate. GAI-122 is being developed as I.V. administered formulation of an intracellular neuroprotectant that employs AlphaRx's proprietary nano-emulsion formulation technology.
The World Health Organization (WHO) recommends a 30 second application of a six-step hand washing and hand rub regimen that could keep infections away.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
The findings are the first to associate decline in body mass index (BMI) with the eventual onset of AD. The researchers suggest that the loss of body mass reflects disease processes and that change in BMI might be a clinical predictor of the development of AD.
› Verified 1 days ago
| Entity Name | North Iowa Eye Clinic, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497863559 PECOS PAC ID: 8426949173 Enrollment ID: O20040322001910 |
News Archive
AlphaRx Inc. announced today that its licensee, Gaia BioPharma Limited, has signed an agreement with a contract manufacturing organization (CMO), to manufacture GAI-122 for use in the planned Phase I and II clinical trials of that product candidate. GAI-122 is being developed as I.V. administered formulation of an intracellular neuroprotectant that employs AlphaRx's proprietary nano-emulsion formulation technology.
The World Health Organization (WHO) recommends a 30 second application of a six-step hand washing and hand rub regimen that could keep infections away.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
The findings are the first to associate decline in body mass index (BMI) with the eventual onset of AD. The researchers suggest that the loss of body mass reflects disease processes and that change in BMI might be a clinical predictor of the development of AD.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandt Michael Riley, DO Po Box 1877, Mason City, IA 50402-1877 Ph: (641) 423-8861 | Dr Brandt Michael Riley, DO Hwy 122, Mason City, IA 50402-1877 Ph: (641) 423-8861 |
News Archive
AlphaRx Inc. announced today that its licensee, Gaia BioPharma Limited, has signed an agreement with a contract manufacturing organization (CMO), to manufacture GAI-122 for use in the planned Phase I and II clinical trials of that product candidate. GAI-122 is being developed as I.V. administered formulation of an intracellular neuroprotectant that employs AlphaRx's proprietary nano-emulsion formulation technology.
The World Health Organization (WHO) recommends a 30 second application of a six-step hand washing and hand rub regimen that could keep infections away.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
The findings are the first to associate decline in body mass index (BMI) with the eventual onset of AD. The researchers suggest that the loss of body mass reflects disease processes and that change in BMI might be a clinical predictor of the development of AD.
› Verified 1 days ago
James Lester Dummett, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3121 4th St Sw, Mason City, IA 50401 Phone: 641-423-8861 Fax: 641-423-0727 | |
Mark Donald Meyer, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3121 4th St Sw, Mason City, IA 50401 Phone: 641-423-8861 Fax: 641-423-0727 | |
Melissa M Summerfield, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3121 4th St Sw, Mason City, IA 50401 Phone: 757-423-8861 Fax: 757-423-0727 | |
Randall Scott Brenton, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3121 4th St Sw, Mason City, IA 50401 Phone: 641-423-8861 Fax: 641-423-0727 | |
Bradney Lee Carter, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3121 4th St Sw, Mason City, IA 50401 Phone: 641-450-0206 | |
Bradley Lemar Isaak, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3121 4th St Sw, Mason City, IA 50401 Phone: 641-423-8861 Fax: 641-423-0727 |